Author： Papapetropoulos Spiridon McCorquodale Donald
Publisher： Future Medicine
ISSN： 1479-6708
Source： Future Neurology, Vol.2, Iss.1, 2007-01, pp. : 29-38
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Kinase signaling pathways: potential therapeutic targets in Parkinson’s disease
Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. :
Access to resources
Recommend
Metabolomic profiling to develop blood biomarkers for Parkinson's disease
Brain, Vol. 131, Iss. 2, 2008-02 ,pp. :
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
By Maarouf Chera L Beach Thomas G Adler Charles H Shill Holly A Sabbagh Marwan N Wu Terence Walker Douglas G Kokjohn Tyler A Roher Alex E PD Consortium Arizona
Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. :
Melatonin in Parkinson's disease
By Medeiros C.
Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. :
A vaccine for Parkinson’s disease?
Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. :